Drug Shortage Report for S.O.S. NALOXONE HYDROCHLORIDE INJECTION

Last updated on 2017-06-26 History
Report ID 3826
Drug Identification Number 02453258
Brand name S.O.S. NALOXONE HYDROCHLORIDE INJECTION
Common or Proper name NALOXONE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) NALOXONE HYDROCHLORIDE
Strength(s) 0.4MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10 X 1ML AMPOULES
ATC code V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2017-04-07
Actual start date
Estimated end date 2017-06-16
Actual end date 2017-05-01
Shortage status Resolved
Updated date 2017-06-26
Company comments Stock available at some wholesalers/Inventaire disponible chez certains grossistes
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2017-06-26 French Compare
v6 2017-06-26 English Compare
v5 2017-04-08 English Compare
v4 2017-03-28 French Compare
v3 2017-03-28 English Compare
v2 2017-03-21 French Compare
v1 2017-03-21 English Compare

Showing 1 to 7 of 7